This inventor holds 4 USPTO granted patents and 4 EPO patents. Top assignees: Hospital Clinic De Barcelona, The United States of America, as Represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 26 
4 out of 3,696 
3 out of 66 
Years Active: 2020-2023
Title: David William Scott: Innovator in Lymphoma Research
Introduction
David William Scott is a notable inventor based in Vancouver, Canada, recognized for his contributions to the field of lymphoma research. With a total of four patents to his name, Scott has made significant strides in developing methods that enhance the understanding and treatment of mantle cell lymphoma.
Latest Patents
Among his latest patents is the invention titled "Evaluation of mantle cell lymphoma and methods related thereto." This invention provides methods for determining a survival predictor score for subjects diagnosed with mantle cell lymphoma (MCL). Additionally, it offers methods for predicting survival outcomes and selecting appropriate treatments for patients with MCL. Another significant patent is the "Method for determining lymphoma type and providing treatment." This invention distinguishes between different lymphoma types based on gene expression measurements, specifically differentiating between PMBCL and DLBCL, and further classifying DLBCL subtypes. These distinctions are crucial for tailoring treatment strategies for patients.
Career Highlights
David William Scott has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Hospital Clinic De Barcelona. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Scott has collaborated with notable colleagues, including Louis M. Staudt and George W. Wright. These partnerships have facilitated the advancement of research in lymphoma and have led to innovative solutions in patient care.
Conclusion
David William Scott's contributions to lymphoma research through his patents and collaborations highlight his commitment to improving patient outcomes. His work continues to influence the field and offers hope for better treatment options for those affected by lymphoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile